Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
eNq1mFFv2jAQx9/5FFHeSUhbCp0C1cbaDanVGC3atJfKJEcxM3Z6toHu088hdKOTo66mfozt/O/i+/vnU9LzzZIFK0BJBe+FSdQKA+CZyCm/74WT28tmNzzvN9IFWZG9ZZ2oFSVHYZAxImUvLGejKRAuo+/XVx/BvA8Y9htBKqYLyNSzdVpRFn0mcn5NinJNkK4EzYMlqLnIe2Gh1XY0SKVCk0V/LfCnLEgGabwb2Z9d3J3sj6dxKfYfqloCXhF+bxUF7qSZaUTgakAU3At8rMn32EmbyjFIoTGDEVHzEYoVzSG3hpgRJsEpyGyd3wCuGKgyiFU8XmRL6SROFmQzhoehPen3ZnagNqrZaiadzlmn3e52uyfHXadQuLdV9iqYj4izu+TotHXcSWLgMQElNlRmDFCwpiLLQnAOjqUaCVSEeSoSlYPnPvMUB+HhRTPkVBaMPEYLWbhuFUFipgENDfx9SPkFt2j4xMye/aPPNWPxK7Oe7OjhKeMSTgOhuaqByOXYdSMGgivY1FfUjXtqs/MiBfl2sr8EtzN/pKeMZq6EMwzSINVkPKwHnEc2fCASJugPDt8oz8Vavj109ovsKftiy02raIF5cnd01j1N2m3nM/XDOKrm/rnQKAqIDY6oPIQyQz4Th/LFmNQu9WRRX+7cNkUiIwxq2qKmI3mMLZ+6OG/G93eoqgmr6KeLW1e3fNWAjzfbR6s0zXt/6uyGZR+sN96sTfz1Tq8OvJeGWaMdJHOlCvkujtfrdTQnsimJ2aVohr65v3fz+uvevVzvVbtTsdNT6tPqUnxdwVwP3ksNwKFN7e79XfNsjaFQwwG1qBjtjaTDi7eH89+O1lvao2cw8Rdm230SRQX31QbpqVXxsOvA1JVfogHEl9mM1vxNqfVlGld/cvqNNC7/4vQbvwHSBP0S
5tZGPWbmpUXTLxTL
